Home > Boards > US OTC > Biotechs > Neuralstem Inc. (CUR)

The market cap of this stock is 7

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
tomhilsen Member Profile
 
Followed By 0
Posts 149
Boards Moderated 0
Alias Born 07/08/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 8:31:36 AM
Neuralstem Announces Issuance of New Patent Covering Broad Therapeutic Use of Neural Stem Cells PR Newswire (US) - 5/16/2019 7:07:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2019 4:35:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2019 4:35:02 PM
Neuralstem Reports First Quarter 2019 Fiscal Results PR Newswire (US) - 5/14/2019 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2019 10:46:06 AM
Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors PR Newswire (US) - 5/6/2019 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2019 4:38:10 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2019 4:36:54 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/19/2019 4:32:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/22/2019 5:32:12 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/22/2019 4:35:08 PM
Neuralstem Reports Year End 2018 Fiscal Results GlobeNewswire Inc. - 3/22/2019 4:30:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 2:56:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/11/2019 2:13:45 PM
Neuralstem to Expand Pipeline as Part of Aggressive Growth Effort PR Newswire (US) - 2/7/2019 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2019 10:23:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2018 5:03:21 PM
Neuralstem Appoints Ken Carter, Ph.D., as Executive Chairman of the Board GlobeNewswire Inc. - 12/18/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/30/2018 5:02:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2018 8:01:29 AM
Neuralstem Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire Inc. - 11/14/2018 5:00:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 4:10:10 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/5/2018 5:07:13 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/29/2018 12:28:42 PM
tomhilsen   Thursday, 12/20/18 02:53:43 PM
Re: None
Post # of 4721 
The market cap of this stock is 7 million usd. NSI 189 has potential to grow neurons in the hippocampus. It has been shown to be safe. Dr. Eva Feldman has shown success in demented mice with injected proprietary stem cells. I think that we are orphan drug status for Angelman’s Syndrome where there is a cognitive deficit in children. Is a chance at treating Alzheimer’s or TBI only worth 7 million usd or is CUR perhaps undervalued?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist